Exec Director, PDM Due Diligence Leader
Scorpion Therapeutics, San Francisco, California, United States, 94199
Role Summary
Executive Director, PDM Due Diligence Leader serves as the PDM representative for corporate development–related due diligence activities, including acquisitions, mergers, licensing, and strategic partnerships. Brings deep and broad CMC expertise across modalities and therapeutic areas. Responsible for synthesizing complex technical, operational, quality and regulatory information from data rooms and expert discussions into clear, executive-level insights, and translating findings into business impact to inform value proposition, risk tolerance, and integration planning. Coaches and mentors part-time Due Diligence leads.
Responsibilities
Be the accountable representative from PDM in due diligence assessments for potential acquisitions, mergers and strategic partnerships.
Partner closely with Corporate Development to define diligence scope, priorities, timelines, and decision criteria.
Identify the functional competencies required for each diligence and work closely with Product and Project Management to assemble high-performing diligence teams with the appropriate SMEs across technical development, manufacturing, quality, regulatory, and supply chain.
Evaluate development, manufacturing, and supply capabilities for biologics (eg, Mabs, ADCs, and advanced therapeutics) and small molecules, including internal and external (CDMO) operating models.
Lead the review and synthesis of large, complex data room materials, identifying key strengths, gaps, dependencies, and execution risks.
Translate technical and operational findings into clear business implications, including cost, timelines, scalability, probability of success, and value proposition.
Identify and articulate technical, regulatory, quality, and supply risks, along with practical and value-preserving mitigation strategies.
Prepare and deliver concise, decision-ready diligence summaries for the various governance forums.
Maintain awareness of the external biopharma landscape, emerging companies, and cutting-edge development and manufacturing technologies.
Serve as a trusted advisor to senior PDM and Corporate Development leadership throughout the deal lifecycle.
Qualifications
Advanced degree (PhD, PharmD, MD, or MS) in a scientific or engineering discipline.
15+ years of experience in biopharmaceutical development and/or manufacturing.
Strong expertise in biologics, including advanced therapeutics, and/or small molecule development and manufacturing.
Experience with due diligence, corporate development, or portfolio strategy.
Broad knowledge of the biopharma landscape, including small, mid-size, and large companies.
Strong business acumen with the ability to connect technical assessments to strategic and financial outcomes.
Exceptional communication skills and executive presence.
Strong interpersonal skills and ability to work with diverse stakeholders across Gilead
#J-18808-Ljbffr
Responsibilities
Be the accountable representative from PDM in due diligence assessments for potential acquisitions, mergers and strategic partnerships.
Partner closely with Corporate Development to define diligence scope, priorities, timelines, and decision criteria.
Identify the functional competencies required for each diligence and work closely with Product and Project Management to assemble high-performing diligence teams with the appropriate SMEs across technical development, manufacturing, quality, regulatory, and supply chain.
Evaluate development, manufacturing, and supply capabilities for biologics (eg, Mabs, ADCs, and advanced therapeutics) and small molecules, including internal and external (CDMO) operating models.
Lead the review and synthesis of large, complex data room materials, identifying key strengths, gaps, dependencies, and execution risks.
Translate technical and operational findings into clear business implications, including cost, timelines, scalability, probability of success, and value proposition.
Identify and articulate technical, regulatory, quality, and supply risks, along with practical and value-preserving mitigation strategies.
Prepare and deliver concise, decision-ready diligence summaries for the various governance forums.
Maintain awareness of the external biopharma landscape, emerging companies, and cutting-edge development and manufacturing technologies.
Serve as a trusted advisor to senior PDM and Corporate Development leadership throughout the deal lifecycle.
Qualifications
Advanced degree (PhD, PharmD, MD, or MS) in a scientific or engineering discipline.
15+ years of experience in biopharmaceutical development and/or manufacturing.
Strong expertise in biologics, including advanced therapeutics, and/or small molecule development and manufacturing.
Experience with due diligence, corporate development, or portfolio strategy.
Broad knowledge of the biopharma landscape, including small, mid-size, and large companies.
Strong business acumen with the ability to connect technical assessments to strategic and financial outcomes.
Exceptional communication skills and executive presence.
Strong interpersonal skills and ability to work with diverse stakeholders across Gilead
#J-18808-Ljbffr